A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis

Update Il y a 4 ans
Reference: NCT00658567

Woman and Man

Extract

This study will evaluate the safety and efficacy of two dose levels of pimavanserin (ACP-103) compared to placebo in patients with Parkinson's disease psychosis.


Inclusion criteria

  • Parkinson's Disease Psychosis


Links